Scientist I, Global Technical Development

Posted 18 Days Ago
Be an Early Applicant
London, Greater London, England
In-Office
Junior
Healthtech • Biotech
The Role
The Scientist I will perform laboratory activities supporting lentiviral vector process development, executing upstream/downstream studies, and generating technical documentation while collaborating with various teams.
Summary Generated by Built In

Location: London, UK (Laboratory based- role)

Reporting to: Principal Scientist, Global Technical Development

Job Summary

Reporting to the Principal Scientist, Global Technical Development, the Scientist I will independently perform laboratory-based activities supporting lentiviral vector (LVV) process development. The role involves execution of upstream and downstream process studies, vector analytics, and generation of high-quality technical documentation, while collaborating with cross-functional teams to support development, technology transfer, and CMC deliverables across the programmes.

Key Elements and Responsibilities

Core Activities

  1. Independently perform assigned laboratory activities for lentiviral vector (LVV) manufacturing process. This may include upstream process (USP) operations (e.g. cell expansion in shake flasks and bioreactor(s), transfection, enhancement and nuclease treatment) and/or downstream process (DSP) operations (e.g. harvest/clarification, tangential flow filtration, chromatography and sterile filtration).
  2. Perform analysis of LVV samples generated from assigned studies. Ensure that experimental results are maintained in relevant databases.
  3. Design and execute experiments with guidance where required, including data analysis and interpretation. Present experimental results and development updates to the wider department or functional teams as requested.
  4. Author, review and data-check development protocols and technical reports, ensuring documentation quality is suitable for internal use and regulatory submission with appropriate review.

Lab maintenance

  1. Author and review standard operating procedures (SOPs) for vector-related equipment and processes and contribute to risk assessments as required.
  2. Contribute to vector laboratory upkeep, including routine laboratory and equipment maintenance, material ordering and inventory management, in line with safety and quality standards.

Broader Technical Development & CMC Exposure

  1. Contribute to capability-building initiatives, including development and application of scale-down models for suspension LVV processes, supporting process understanding and optimization at larger scale.
  2. Support process characterization and validation activities ahead of PPQ, in alignment with current industry standards, CMC regulatory expectations and best practices in cell and gene therapy.
  3. Involved in development, integration and implementation of (new) vector processes either at OTL labs or at external partners (e.g. CDMOs). This may include technology transfer initiatives between laboratories.
  4. Potentially participate in early-phase CMC program team activities, including cross-functional collaboration, to support completion of key project goals. Support CMC activities as required, including generation of source documents and/or conducting data integrity (DI) checks.
  5. Collaborate with process research, pre-clinical, QA, MSAT and other departments to support delivery of project timelines and milestones.
  6. Other duties as assigned.

Requirements

Required Knowledge

·         Expected approximately 2 to 5 years’ experience depending on scope and relevance, in biotechnology/biological sciences, with a primary focus on cell and gene therapy.

·         Experience in Upstream Process (USP) operations for vector production for adherent and/or suspension cell-based platforms. Hands-on experience with suspension bioreactors is highly desirable.

·         Experience in Downstream Process (DSP) operations including clarification/filtration, chromatography, tangential flow filtration and sterile steps. Practical / hands-on experience with DSP processes is highly desirable.

·         Understanding of analytical methods associated with gene therapy vectors and /or autologous gene-modified cellular therapies. Practical experience in vector analytics is highly desirable.

·         Capable of independently designing and/or conducting experiments, analyzing data and effectively managing their time.

·         Basic understanding of regulatory filings and associated reports/sections writing and knowledge of FDA, EMA, GMP and ICH regulatory requirements a plus.

·         DOE, QBD and Benchling experience a plus.

Skills and Abilities

·         Excellent interpersonal skills

·         Positive can-do attitude

·         Outstanding organizational skills

·         Excellent written and oral communication skills

·         Creative problem solver

·         Ability to operate in a fast-paced, multi-disciplinary industrial environment

·         Experience authoring development reports preferred

Education

·         BSc, MSc or PhD in bioprocessing, biological sciences, gene therapy or related subject.

Top Skills

Benchling
Biological Sciences
Biotechnology
Cell-Based Platforms
Doe
Downstream Process (Dsp)
Ema
Fda
Gene Therapy
Gmp
Ich Regulatory Requirements
Qbd
Suspension Bioreactors
Upstream Process (Usp)
Vector Analytics
Am I A Good Fit?
beta
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Boston, MA
196 Employees
Year Founded: 2015

What We Do

At Orchard Therapeutics, our vision is to end the devastation caused by genetic and other severe diseases. We aim to do this by discovering, developing and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease in a single treatment.

In 2018, the company acquired GSK’s rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Today, Orchard is advancing a pipeline spanning pre-clinical, clinical and commercial stage HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist.

Orchard has its global headquarters in London and U.S. headquarters in Boston. For more information, please visit www.orchard-tx.com,

Similar Jobs

Snap Inc. Logo Snap Inc.

Head of UK Marketing

Artificial Intelligence • Cloud • Machine Learning • Mobile • Software • Virtual Reality • App development
Hybrid
London, Greater London, England, GBR
5000 Employees

Citadel Securities Logo Citadel Securities

Quantitative Researcher

Information Technology • Software • Financial Services
In-Office
London, Greater London, England, GBR
1900 Employees

CrowdStrike Logo CrowdStrike

Intelligence Analyst, Recon+ (Remote)

Cloud • Computer Vision • Information Technology • Sales • Security • Cybersecurity
Remote or Hybrid
3 Locations
10000 Employees

Navan Logo Navan

Mid-Market Launch Manager - (French Speaker)

Fintech • Information Technology • Payments • Productivity • Software • Travel • Automation
Easy Apply
Hybrid
London, Greater London, England, GBR
3300 Employees

Similar Companies Hiring

Camber Thumbnail
Social Impact • Healthtech • Fintech
New York, NY
53 Employees
Sailor Health Thumbnail
Telehealth • Social Impact • Healthtech
New York City, NY
20 Employees
Granted Thumbnail
Mobile • Insurance • Healthtech • Financial Services • Artificial Intelligence
New York, New York
23 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account